| __timestamp | Opthea Limited | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2652041 | 1860000 |
| Thursday, January 1, 2015 | 2361587 | 2963000 |
| Friday, January 1, 2016 | 4472869 | 6961000 |
| Sunday, January 1, 2017 | 5030957 | 11779000 |
| Monday, January 1, 2018 | 4988941 | 13697000 |
| Tuesday, January 1, 2019 | 5196412 | 15749000 |
| Wednesday, January 1, 2020 | 6652774 | 18638000 |
| Friday, January 1, 2021 | 18418247 | 27196000 |
| Saturday, January 1, 2022 | 24827066 | 31739000 |
| Sunday, January 1, 2023 | 41896408 | 33491000 |
| Monday, January 1, 2024 | 15488619 |
Unleashing insights
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Opthea Limited and Protagonist Therapeutics, Inc. from 2014 to 2023. Over this period, Protagonist Therapeutics consistently outspent Opthea, peaking in 2023 with expenses 80% higher than in 2014. Opthea, however, saw a dramatic increase in 2023, with expenses surging by over 1,500% compared to 2014. This sharp rise suggests a strategic shift or expansion. Interestingly, 2024 data for Protagonist is missing, indicating potential reporting delays or strategic changes. Understanding these trends offers insights into each company's operational strategies and market positioning. As the biotech sector evolves, monitoring SG&A efficiency remains vital for investors and stakeholders aiming to gauge financial health and strategic direction.
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Opthea Limited
Opthea Limited or Xenon Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Opthea Limited and Merus N.V.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Opthea Limited and Ligand Pharmaceuticals Incorporated
Selling, General, and Administrative Costs: Opthea Limited vs Geron Corporation
PTC Therapeutics, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: MorphoSys AG vs Protagonist Therapeutics, Inc.
Comparing SG&A Expenses: Protagonist Therapeutics, Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Protagonist Therapeutics, Inc. vs Wave Life Sciences Ltd.
Breaking Down SG&A Expenses: Protagonist Therapeutics, Inc. vs Dynavax Technologies Corporation
Selling, General, and Administrative Costs: Protagonist Therapeutics, Inc. vs Celldex Therapeutics, Inc.